Elsevier Inc.

SHERPA: Unknown

People

  1. Aghajanian
    Aghajanian
  2. Chi
    Chi
  3. Abu-Rustum
    Abu-Rustum
  4. Sabbatini
    Sabbatini
  5. Alektiar
    Alektiar
  6. Hensley
    Hensley
  7. Konner
    Konner
  8. Leitao
    Leitao
  9. Zivanovic
    Zivanovic
  10. Gardner
    Gardner

Groups

  1. Department of Medicine (15)
  2. GDMT, Medicine (15)
  3. Gynecologic Medicine Service (15)
  4. Gynecology Disease Management Team (15)
  5. Solid Tumor Oncology Division (15)
  6. Surgery (11)
  7. GDMT, Surgery (10)
  8. GDMT, Pathology and Laboratory Medicine (6)
  9. GDMT, Radiation Oncology (5)
  10. Radiation Oncology, Department of (5)
Search Within
  1. "2009"
  2. "Gynecologic Medicine Service"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (15)
  2. GDMT, Medicine (15)
  3. Gynecologic Medicine Service (15)
  4. Gynecology Disease Management Team (15)
  5. Solid Tumor Oncology Division (15)
  6. Surgery (11)

More Groups

People
  1. Richard Barakat (9)
  2. Carol Aghajanian (8)
  3. Dennis Chi (8)
  4. Nadeem Abu-Rustum (7)
  5. Paul Sabbatini (6)
  6. Douglas Levine (5)

More People

Years
  1. 2009 (15)
Publications
  1. Gynecologic Oncology (14)
  2. Clinical Ovarian Cancer (1)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Haplotype analysis of bevacizumab-induced hypertension
    Meeting Abstract

    Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J.; Barakat, R. R.; Dickler, M.; Levine, D. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Clinical features and oncologic outcomes in endometrial stromal sarcoma
    Meeting Abstract

    dos Santos, L. A.; Garg, K.; Diaz, J. P.; Soslow, R. A.; Hensley, M. L.; Alektiar, K. M.; Barakat, R. R.; Leitao, M. M.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Incidence and management of bevacizumab-associated gastrointestinal perforation in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Diaz, J. P.; Zivanovic, O.; Tew, W. P.; Konner, J.; Sabbatini, P. J.; Chi, D. S.; Aghajanian, C.; Barakat, R. R.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Does clear cell endometrial carcinoma have a prognosis similar to that of serous endometrial carcinoma?
    Meeting Abstract

    Abu-Rustum, N. R.; Zhou, Q. C.; Iasonos, A.; Soslow, R. A.; Sabbatini, P. J.; Levine, D. A.; Alektiar, K. M.; Chi, D. S.; Barakat, R. R.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer
    Journal Article

    Zivanovic, O.; Sima, C. S.; Iasonos, A.; Bell-Mcguinn, K. M.; Sabbatini, P. J.; Leitao, M. M.; Levine, D. A.; Gardner, G. J.; Barakat, R. R.; Chi, D. S.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy
    Journal Article

    Zivanovic, O.; Leitao, M. M. Jr; Park, K. J.; Zhao, H.; Diaz, J. P.; Konner, J.; Alektiar, K.; Chi, D. S.; Abu-Rustum, N. R.; Aghajanian, C.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
    Journal Article

    Schilder, R. J.; Pathak, H. B.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Aghajanian, C.; Min, H.; Devarajan, K.; Ross, E.; Drescher, C. W.; more...
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies
    Journal Article

    Kehoe, S. M.; Williams, N. L.; Yakubu, R.; Levine, D. A.; Chi, D. S.; Sabbatini, P. J.; Aghajanian, C. A.; Barakat, R. R.; Abu-Rustum, N. R.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
    Journal Article

    Hensley, M. L.; Sill, M. W.; Scribner, D. R. Jr; Brown, J.; DeBernardo, R. L.; Hartenbach, E. M.; McCourt, C. K.; Bosscher, J. R.; Gehrig, P. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study
    Journal Article

    Hensley, M. L.; Ishill, N.; Soslow, R.; Larkin, J.; Abu Rustum, N.; Sabbatini, P.; Konner, J.; Tew, W.; Spriggs, D.; Aghajanian, C. A.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save